---
schema_version: "secwatch.filing_event.v1"
accession: "0001428336-24-000009"
form_type: "8-K"
ticker: "HQY"
cik: "0001428336"
company_name: "HEALTHEQUITY, INC."
filed_at: "2024-03-19T23:59:59+00:00"
generated_at: "2026-06-04T13:13:07.414945+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# HealthEquity FY2024 revenue $999.6M (+16%), net income $55.7M vs loss; Q4 beat; guides FY2025 rev ~$1.15B

## Summary
- FY 2024 revenue $999.6M (+16% YoY); net income $55.7M vs loss $26.1M; GAAP EPS $0.64 vs -$0.31.
- Q4 revenue $262.4M (+12%); net income $26.4M vs loss; adj EBITDA $98.8M (+34%, margin 38%).
- HSA accounts 8.7M (+9%), assets $25.2B (+14%); total accounts 15.7M.
- Acquired first BenefitWallet tranche: 266k HSAs, $1.1B assets for $163.9M cash; $425M total deal.
- FY 2025 guidance: rev $1.14-1.16B; adj EBITDA $438-458M; non-GAAP EPS $2.79-2.96.

## SEC filing metadata
- accession: 0001428336-24-000009
- form_type: 8-K
- ticker: HQY
- cik: 0001428336
- company_name: HEALTHEQUITY, INC.
- filed_at: 2024-03-19T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1428336/000142833624000009/0001428336-24-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1428336/000142833624000009/hqy-20240319.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001428336-24-000009
- JSON: https://secwatch.observer/filing/0001428336-24-000009.json
- Plain text: https://secwatch.observer/filing/0001428336-24-000009.txt

## Key facts
- Earnings Releases
  HEALTHEQUITY, INC. reported the fiscal year ended January 31, 2024 results: revenue $999.6 million, net income $55.7 million, EPS $0.64 per diluted share.
  - Period: the fiscal year ended January 31, 2024
  - Revenue: $999.6 million
  - Net income: $55.7 million
  - EPS: $0.64 per diluted share
  - Result: reported results
  source text: --- EX-99.1 (EX-99.1) --- HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial Results Highlights of the fiscal year include: • Revenue of $999.6 million, an increase of 16% compared to $861.7 million in FY23. • Net income of $55.7 million, compared to net loss of $26.1 million in FY23, with non-GAAP net income of $195.5 million,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1428336/000142833624000009/0001428336-24-000009-index.htm
- Earnings Releases
  HEALTHEQUITY, INC. reported the fourth quarter ended January 31, 2024 results: revenue $262.4 million, net income $26.4 million, EPS $0.30 per diluted share.
  - Period: the fourth quarter ended January 31, 2024
  - Revenue: $262.4 million
  - Net income: $26.4 million
  - EPS: $0.30 per diluted share
  - Result: reported results
  source text: Revenue for the fourth quarter ended January 31, 2024 was $262.4 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1428336/000142833624000009/0001428336-24-000009-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.